Results for tag: "Pulmozyme"

Pulmozyme is a respiratory drug used to treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. It is a recombinant form of the human protein deoxyribonuclease (DNase) and works by breaking down the thick mucus that builds up in the lungs of cystic fibrosis patients. Pulmozyme is administered through inhalation and is the only approved drug for this purpose. It is also used to reduce the risk of pulmonary exacerbations, which are episodes of worsening symptoms. Pulmozyme is a part of the larger respiratory drug market, which includes drugs used to treat a variety of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory illnesses. These drugs are used to reduce symptoms, improve quality of life, and prevent exacerbations. Some companies in the Pulmozyme market include Genentech, Vertex Pharmaceuticals, and GlaxoSmithKline. Show Less Read more